頭蓋内動脈狭窄を伴う再発性脳卒中に対するシロスタゾール・アスピリン併用療法

基本情報

NCT ID: NCT00333164
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 200
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

Multi-center, open-labelled randomized controlled trial, to study the effect of aspirin plus cilostazol and aspirin alone on the progression of intracranial arterial stenosis, in 200 chronic stroke patients with 50-99% stenosis, to be followed up for 2 years

対象疾患

Cerebrovascular Disease

介入

Asprin, Cilostazol(DRUG)

依頼者（Sponsor）

Foundation For Biomedical Research And Innovation(OTHER)

Kobe City General Hospital(OTHER)

Tohoku University(OTHER)

Kyushu University(OTHER)

China National Center For Cardiovascular Diseases(OTHER_GOV)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

Neurology, Tokyo Women's Medical University, School Of Medicine(OTHER)

Department Of Neurology, Saiseikai Central Hospital(UNKNOWN)

実施施設 (1)

東京女子医科大学病院

Shinjuku-ku, Tokyo, Japan